首页 › 弥漫性大B细胞淋巴瘤 › 佛罗里达州 › Jacksonville
Jacksonville FL 弥漫性大B细胞淋巴瘤临床试验
8项针对 弥漫性大B细胞淋巴瘤的研究正在 Jacksonville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- Mayo Clinic Jacksonville, Jacksonville
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
招募中2 期
- Baptist MD Anderson Cancer Center ( Site 0176), Jacksonville
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
招募中3 期
- Mayo Clinic Jacksonville, Jacksonville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Mayo Clinic Florida, Jacksonville
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
招募中1 期
- Mayo Clinic, Jacksonville
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
招募中1 期
- Mayo Clinic in Florida, Jacksonville
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
招募中2 期
- Mayo Clinic in Florida, Jacksonville
其他城市的 弥漫性大B细胞淋巴瘤试验
- New York City, NY21 项研究
- Baldwin Park, CA19 项研究
- Chicago, IL18 项研究
- Houston, TX17 项研究
- Los Angeles, CA17 项研究
- Milwaukee, WI16 项研究
- Boston, MA16 项研究
- Philadelphia, PA15 项研究
- Portland, OR15 项研究
- Durham, NC14 项研究
- Nashville, TN14 项研究
- Dallas, TX13 项研究
Jacksonville的其他研究
- 乳腺癌40 项研究
- 非小细胞肺癌40 项研究
- 癌症（所有类型）30 项研究
- 转移性癌症28 项研究
- 结直肠癌27 项研究
- 前列腺癌26 项研究
- 肥胖症25 项研究
- 心力衰竭21 项研究
- 胰腺癌21 项研究
- 超重19 项研究
- 多发性骨髓瘤18 项研究
- 肺癌17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。